Xeris Biopharma Holdings, Inc.
XERS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867096
In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 10 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Xeris Biopharma Holdings, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 144
- +11 vs. Q2 2024
- Shares held
- 63.9M
- +13.5M (+26.9%) vs. Q2 2024
- Total value
- $182.2M
- +$68.9M (+60.8%) vs. Q2 2024
- New holders
- 25
- 47 more added
- Sold out
- 14
- 35 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XERS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 242 | $857.1M |
| Q1 2026 | 239 | $610.3M |
| Q4 2025 | 227 | $792.0M |
| Q3 2025 | 231 | $789.3M |
| Q2 2025 | 201 | $422.9M |
| Q1 2025 | 199 | $480.9M |
| Q4 2024 | 162 | $222.2M |
| Q3 2024 | 144 | $182.2M |
| Q2 2024 | 135 | $136.6M |
| Q1 2024 | 142 | $133.7M |
| Q4 2023 | 120 | $140.8M |
| Q3 2023 | 111 | $102.3M |
| Q2 2023 | 105 | $146.7M |
| Q1 2023 | 92 | $80.6M |
| Q4 2022 | 97 | $71.6M |
| Q3 2022 | 101 | $89.3M |
| Q2 2022 | 103 | $91.3M |
| Q1 2022 | 103 | $129.2M |
| Q4 2021 | 92 | $120.2M |
| Q3 2021 | 71 | $42.9M |
| Q2 2021 | 94 | $114.9M |
| Q1 2021 | 103 | $149.7M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Xeris Biopharma Holdings, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alliancebernstein L.P. | 147,720 | $421.0K | 0.00% | 00.0% | Unchanged |
| Alpine Global Management, LLC | 160,000 | $456.0K | 0.11% | −140,000−46.7% | Reduced |
| Price T Rowe Associates Inc | 160,976 | $459.0K | 0.00% | +30,008+22.9% | Added |
| Fairfax Financial Holdings LtdSuperinvestorFairfax Financial | 170,937 | $485.5K | 0.04% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 172,327 | $491.1K | 0.00% | −163,720−48.7% | Reduced |
| Thompson Siegel & Walmsley LLC | 172,784 | $492.0K | 0.01% | 00.0% | Unchanged |
| Rhumbline Advisers | 173,556 | $494.6K | 0.00% | −16,414−8.6% | Reduced |
| Diversified Trust Co | 175,739 | $500.9K | 0.01% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 187,443 | $534.0K | 0.00% | +440+0.2% | Added |
| Brown Advisory Inc | 190,255 | $542.2K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 210,843 | $600.9K | 0.00% | +195,973+1,317.9% | Added |
| Ameriprise Financial Inc | 217,089 | $618.7K | 0.00% | −2,817−1.3% | Reduced |
| Qube Research & Technologies Ltd | 241,571 | $688.5K | 0.00% | +217,668+910.6% | Added |
| IHT Wealth Management, LLC | 276,885 | $789.1K | 0.02% | −19,450−6.6% | Reduced |
| UBS Group AG | 283,252 | $807.3K | 0.00% | +119,613+73.1% | Added |
| Jane Street Group, LLC | 318,760 | $908.5K | 0.00% | −28,832−8.3% | Reduced |
| Barclays PLC | 324,472 | $924.7K | 0.00% | +151,685+87.8% | Added |
| Bank of New York Mellon Corp | 329,248 | $938.4K | 0.00% | −99,306−23.2% | Reduced |
| Lazard Asset Management LLC | 378,339 | $1.08M | 0.00% | −257,905−40.5% | Reduced |
| JPMorgan Chase & Co | 391,960 | $1.12M | 0.00% | +67,557+20.8% | Added |
| Charles Schwab Investment Management Inc | 403,361 | $1.15M | 0.00% | −1,221−0.3% | Reduced |
| Wellington Management Group LLP | 471,644 | $1.34M | 0.00% | +49,535+11.7% | Added |
| Tudor Investment Corp Et Al | 507,357 | $1.45M | 0.02% | −65,829−11.5% | Reduced |
| Kennedy Capital Management, Inc. | 604,857 | $1.72M | 0.04% | +604,857 | New |
| Goldman Sachs Group Inc | 836,442 | $2.38M | 0.00% | +520,778+165.0% | Added |
| D. E. Shaw & Co., Inc. | 985,015 | $2.81M | 0.00% | +466,991+90.1% | Added |
| Knott David M Jr | 1,000,000 | $2.85M | 1.14% | +180,000+22.0% | Added |
| Bank of America Corp | 1,009,201 | $2.88M | 0.00% | +367,535+57.3% | Added |
| Redmile Group, LLC | 1,046,587 | $2.98M | 0.18% | 00.0% | Unchanged |
| AQR Capital Management LLC | 1,068,116 | $3.04M | 0.00% | −124,964−10.5% | Reduced |
| Walleye Capital LLC | 1,121,738 | $3.20M | 0.03% | +1,121,738 | New |
| Northern Trust Corp | 1,158,226 | $3.30M | 0.00% | +51,057+4.6% | Added |
| Millennium Management LLC | 1,445,699 | $4.12M | 0.00% | −250,825−14.8% | Reduced |
| Renaissance Technologies LLC | 1,598,720 | $4.56M | 0.01% | +247,080+18.3% | Added |
| Nuveen Asset Management, LLC | 1,675,062 | $4.77M | 0.00% | +332,450+24.8% | Added |
| AIGH Capital Management LLC | 2,185,654 | $6.23M | 2.92% | +2,185,654 | New |
| Morgan Stanley | 2,354,308 | $6.71M | 0.00% | +744,384+46.2% | Added |
| Rosalind Advisors, Inc. | 3,104,995 | $8.85M | 5.87% | −15,175−0.5% | Reduced |
| State Street Corp | 3,204,718 | $9.13M | 0.00% | −53,915−1.7% | Reduced |
| Geode Capital Management, LLC | 3,333,470 | $9.50M | 0.00% | +93,091+2.9% | Added |
| CenterBook Partners LP | 3,482,006 | $9.92M | 0.61% | +2,016,131+137.5% | Added |
| Caxton Corp | 5,113,348 | $14.6M | 60.31% | 00.0% | Unchanged |
| Vanguard Group Inc | 7,765,325 | $22.1M | 0.00% | +108,435+1.4% | Added |
| BlackRock, Inc. | 10,734,031 | $30.6M | 0.00% | +10,734,031 | New |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −4,830,526−100.0% | Sold out |
| Invenomic Capital Management LP | 0 | $0 | 0.00% | −592,078−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −118,443−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −62,083−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −48,663−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −26,803−100.0% | Sold out |
| Sanctuary Advisors, LLC | 0 | $0 | 0.00% | −33,429−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −23,559−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,900−100.0% | Sold out |
| Simplicity Wealth,LLC | 0 | $0 | 0.00% | −12,156−100.0% | Sold out |
| TownSquare Capital, LLC | 0 | $0 | 0.00% | −11,267−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −1,890−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Benjamin F. Edwards & Company, Inc. | – | – | – | – | Not filed |